% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Wagner:62451,
author = {Wagner, Franziska M.},
title = {{Z}ur {S}ynthese radiofluorierter aromatischer
{A}minosäuren mittels {I}sotopenaustausch am {B}eispiel von
6-[$^{18}${F}]{F}luor-{L}-{DOPA}},
volume = {4273},
issn = {0944-2952},
school = {Univ. Köln},
type = {Dr. (Univ.)},
address = {Jülich},
publisher = {Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag},
reportid = {PreJuSER-62451, Juel-4273},
series = {Berichte des Forschungszentrums Jülich},
pages = {III, 188 p.},
year = {2008},
note = {Record converted from VDB: 12.11.2012; Köln, Univ., Diss.,
2008},
abstract = {In nuclear medical diagnosis,
6-[$^{18}$F]fluoro-L-3,4-dihydroxyphenylalanine
(6-[$^{18}$F]fluoro-LDOPA), an analogue of L-DOPA, is one of
the few established radiopharmaceuticals used for the in
vivo investigation of the presynaptic dopaminergic
metabolism and of some kind of tumours via Positron Emission
Tomography (PET). The presently used method of preparation
of the radiotracer by electrophilic labelling is limited to
low amounts of activity at high costs. Known nucleophilic
syntheses, however, result either in insufficient
enantiomeric purity or the known multi-step syntheses are
hard to automate, due to their complexity. During this work
a novel, easy to automate alternative for the preparation of
6-[$^{18}$F]fluoro-L-DOPA, was developed and evaluated,
using a direct nucleophilic $^{18}$F-fluorination of a
protected amino acid derivative. The resulting product has a
very high enantiomeric purity. At first, the general
suitability of the (S)-BOC-BMI-derivatives for the synthesis
of $^{18}$F-labelled amino acids, used in this work, was
investigated using a less complex precursor, which resulted
in the amino acid 6-[$^{18}$F]fluoro-L-m-tyrosin via acidic
hydrolysis. The preparation of a useful precursor for the
nucleophilic $^{18}$F-isotope substitution, namely the
(2S,5S)-tert.-butyl-5-(2-fluoro-5-formylbenzyl)-2-tert.-butyl-3-methyl-4-oxoimidazolidine-1-carboxylate,
was investigated in three general different ways. At first
it was tried to obtain this product via formylation after
coupling with the BOC-BMI, secondly via a,b-dehydro amino
acid derivatives and finally via a systematic multi-step
synthesis. Only the last mentioned way resulted in a
precursor with sufficient purity that could be labelled. The
radiochemical yield of the isotopic exchange was about 60
\%. In the next step, the presented concept was modified to
synthesize a precursor for the preparation of
6-[$^{18}$F]fluoro-L-DOPA. Only a combination of the
protecting groups benzyl and THP resulted in the useful
precursor
(2S,5S)-tert.-butyl-5-(4-benzyloxy-2-fluoro-5-formylbenzyl)-2-tert.-butyl-3-methyl-4-oxoimidazolidine-1-carboxylate.
By optimisation of the isotopic exchange with [18F]fluoride
on this precursor a radiochemical yield of about 50 \% was
achieved. After a three step synthesis including the
labelling, a Baeyer-Villiger-oxidation using mCPBA and a
hydrolysis using HBr, c.a. 6-[$^{18}$F]fluoro-L-DOPA was
isolated containing more than 99 \% of the desired L-isomer.
The complete preparation and isolation of c.a.
6-[$^{18}$F]fluoro-L-DOPA, using optimised conditions,
resulted in a decay corrected yield of about 22 \% after a
synthesis time of 105 minutes. Thus the presented synthesis
of 6-[$^{18}$F]fluoro-L-DOPA is not only more efficient than
the known methods of preparation, but is furthermore fully
automatable.},
cin = {INB-4},
cid = {I:(DE-Juel1)VDB807},
pnm = {Funktion und Dysfunktion des Nervensystems},
pid = {G:(DE-Juel1)FUEK409},
typ = {PUB:(DE-HGF)11 / PUB:(DE-HGF)3},
url = {https://juser.fz-juelich.de/record/62451},
}